The University of Chicago Header Logo

Connection

Hedy Kindler to Triazines

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Triazines.
Hedy Kindler
Connection Strength
0.009
Triazines
  1. Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol. 1997 Dec; 8(12):1269-71.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.